Funding awarded to develop a global Pathogen Data Network
EMBL-EBI and colleagues from other 11 institutes commit to pathogen data sharing project.
2024
announcements
Read the latest Issue
Using Data Hubs to analyse SARS-CoV-2 and other pathogen sequences
The SARS-CoV-2 Data Hubs are a set of tools coupled with infrastructure that support four components: the submission, analysis, presentation and visualisation of SARS-CoV-2 raw read data, and its resulting analyses. What makes Data Hubs attractive is a unique set of features: A new publication in…
2024
updates-from-data-resources
Extending the network of infectious disease data portals: developments in Sweden and The Netherlands
Two new data portals are set to support infectious disease monitoring and research across Europe; the Swedish Pathogens Data Portal and the Netherlands COVID-19 Data Portal.
2023
updates-from-data-resources
Pathogens Portal: The new gateway to public pathogen data
Science & Technology Enabling researchers worldwide to share and analyse pathogen data generated across the world
2023
sciencescience-technologytechnology-and-innovation
Welcome: John Lees
Lab MattersPeople & Perspectives John Lees joins EMBL-EBI as a Group Leader in Pathogen informatics and modelling.
2022
lab-matterspeople-perspectives
Pathogen data sharing – key to pandemic preparedness
Science & Technology Researchers lay out a set of principles for open genomic data sharing or pathogens
2022
perspectivesscience-technology
A new era for European molecular biology
EMBL AnnouncementsLab Matters EMBL announces details about its next programme, ‘Molecules to Ecosystems’. It will guide studying life across scales and in context with changing environments.
2022
announcementsembl-announcementslab-matters
Sorting out HIV
Science & Technology An EMBL collaboration devises a new method that could speed up vaccine development for HIV
2017
sciencescience-technology
Structure of key system for TB infection
Science & Technology EMBL scientists add crucial knowledge to understanding of the bacterium that causes tuberculosis
2017
sciencescience-technology
Microbiomes: Our humble overlords
Science & Technology What's a microbiome? How on Earth do they work?
2016
sciencescience-technology
Pandemic! A public event
EMBL-EBI organises an evening of talks and discussion about the global spread of infectious disease.
2015
events
Awards & Honours
Lab Matters EMBL scientists regularly receive prestigious awards – meet the latest honourees.
2015
lab-matters
Fighting bacteria – with viruses
Molecular switch enables viruses to destroy C.diff bacteria – potential alternative to antibiotics
2014
science
The future’s bright
Surprising protein from a flu-like virus is 10 000th ESRF structure
2014
science
Nothing but blue skies
Focusing on basic research is crucial for the development of more advanced genetics techniques
2014
science
HIV: hacking, immaturity and viruses
Science & Technology High-resolution structure reveals crucial interactions for HIV maturation
2014
sciencescience-technology
Tsetse fly genome sequenced
Science & Technology Tsetse fly genome sequenced; scientists hope to find new ways to control sleeping sickness.
2014
sciencescience-technology
Catching the cap-snatcher
Science & Technology Researchers at the European Molecular Biology Laboratory (EMBL) in Grenoble, France, have determined the detailed 3-dimensional structure of part of the flu virus’ RNA polymerase, an enzyme that is crucial for influenza virus replication. This important finding is published today in PLoS…
2012
sciencescience-technology
A stepwise retreat: how immune cells catch pathogens
To protect us from disease our immune system employs macrophages, cells that roam our body in search of disease-causing bacteria. With the help of long tentacle-like protrusions, macrophages can catch suspicious particles, pull them towards their cell bodies, internalise and destroy them. Using a…
2007
science
New compound effectively treats fungal infections
A new mechanism to attack hard-to-treat fungal infections has been revealed by scientists from the biotech company Anacor Pharmaceuticals Inc., California, and the European Molecular Biology Laboratory [EMBL] outstation in Grenoble, France. In the current issue of Science they describe…
2007
science
No matching posts found
